FDA Issued Warning to Amazon Over Herpes Treatments
The agency cited the sale of unapproved drugs marketed for sexually transmitted infections.
Updated on Oct. 7, 2026 in Healthcare
Live Poll
Do you trust online retailers to ensure health products sold on their platforms are safe?
The Food and Drug Administration has sent a warning letter to Amazon regarding the sale of numerous unapproved over-the-counter herpes treatments. The agency identified several products sold on the platform that lack formal approval as new drugs.
Why it matters
The FDA warns that selling unapproved medical products poses a significant public health risk, as consumers might forgo seeking appropriate medical care for sexually transmitted infections. The agency requires that all such products undergo rigorous regulatory review before being sold to the public.
The FDA identified nine specific products, including FemiClear and Herstat GST, as unapproved new drugs following an investigation of products purchased in July 2026. The agency has given the retailer a deadline of 15 business days to provide a written response.
The players
Food and Drug Administration
This federal agency is responsible for protecting public health by ensuring the safety, efficacy, and security of human drugs and biological products in the United States.
Amazon
This multinational technology company operates one of the world's largest e-commerce platforms and retail marketplaces.
The details
Federal regulators purchased multiple herpes treatments from Amazon to evaluate compliance with drug approval requirements and ingredient standards. The agency concluded that the products did not meet the criteria for safe, approved medical treatments for sexually transmitted infections.
Timeline
In July 2026, the FDA purchased multiple herpes products from the Amazon website.
On October 1, 2026, the FDA issued a formal warning letter to Amazon.
Amazon must submit a written response to the FDA within 15 business days of October 1, 2026.
Market Landscape
This action continues a pattern of regulatory oversight where the FDA targets the marketplace practices of major e-commerce platforms. It highlights the friction between the retail model of massive online stores and federal standards for medical product verification.
Customers who have purchased these products should consult a medical professional for appropriate treatment of sexually transmitted infections. Shoppers should be aware that the availability of a health product on major retail platforms does not guarantee that the item has been reviewed or approved by the FDA.
The takeaway
Consumers should verify that health products have official FDA approval before relying on them for medical treatment. Always rely on guidance from licensed healthcare providers rather than unverified over-the-counter solutions for serious medical conditions.
Further reading
For more on the intersection of medical commerce and federal oversight, visit the Healthcare section.
Live Poll
Do you trust online retailers to ensure health products sold on their platforms are safe?
